Hyalex のファースト・イン・ヒューマン研究
HYALEX® 軟骨システムの前向き多施設シングルアーム 2 フェーズ First-in-Human 実現可能性研究
The Hyalex First-in-Human Study is a prospective, multicenter, open-label, single-arm, 2-phase, first-in-human study to evaluate the safety and technical performance of the HYALEX Knee Cartilage System for replacement of loss of articular cartilage and bone of the knee femoral condyles in symptomatic patients who require surgical treatment.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Lodz、ポーランド、09-038
- SPORTO
-
Warsaw、ポーランド、00-855
- LIFE Medical Center
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria - Phase 1
- 21-65 years.
- Body Mass Index (BMI) ≤ 35.
- Singular treatable joint surface lesion, ICRS Grade 3 or 4, located on the medial or lateral femoral condyle.
- Symptomatic, single treatable area 1 - 3.8cm2.
- Knee Injury and Osteoarthritis Outcome Score (KOOS) pain subscale score between 20 and 65.
- Stable knee.
- Non-responsive to a minimum of 3 weeks of conservative treatment, consisting of non-steroidal anti-inflammatory drugs and/or physical therapy.
Inclusion Criteria - Phase 2
- 21-65 years.
- Body Mass Index (BMI) ≤ 35.
- Up to three treatable joint surface lesion(s), ICRS Grade 3 or 4, located on the medial or lateral femoral condyle(s).
- Symptomatic total treatable area 1 - 10cm2.
- Knee Injury and Osteoarthritis Outcome Score (KOOS) pain subscale score between 20 and 65.
- Stable knee.
- Non-responsive to a minimum of 3 weeks of conservative treatment, consisting of non-steroidal anti-inflammatory drugs and/or physical therapy.
Exclusion Criteria - Phase 1 & 2
HYALEX Implant, Surgical Technique, and Lesion Site Exclusions:
- Known allergy to polyurethanes, bone cement, acrylic, or titanium.
- Lack of 2mm of healthy cartilage (ICRS Grade 0 or 1) and 2mm of vital bone wall on all sides of the implant site.
- Osteochondral defect affecting subchondral bone more than 11mm in depth from adjacent non-defect articular surface.
- Bipolar cartilage lesions involving patellar or tibial lesions ICRS Grade 3 - 4 opposite the lesion intended for treatment.
- Insufficient bone stock or bone density determined intra-operatively preventing implant press fit.
Patient Orthopaedic Health Exclusions:
- Kellgren and Lawrence (KL) grade 3 or 4 on standing radiographs as defined:
- Hip-knee-ankle (HKA) angle of greater than +/- 5 degrees (varus or valgus malalignment > 5 degrees) on standing X-ray.
- Lack of normally functioning contralateral knee that restricts activity.
- Insufficiency fracture of the femoral condyle or tibial plateau.
- Recent Osteochondritis Dissecans within 1 year.
- Diagnosis of a concomitant knee injury which the investigator believes may interfere with study participation or confound effectiveness assessment.
- Any known systemic cartilage and/or bone disorder, such as but not limited to osteoporosis, chondrodysplasia or osteogenesis imperfecta.
- A symptomatic musculoskeletal condition in the lower limbs that could impede effectiveness measurements in the target knee.
- Any known tumor of the treatment knee.
- Prior radiation therapy to the knee joint.
- Clinically significant or symptomatic vascular or neurological disorder of the lower extremities affecting gait or function.
- Untreated ACL and/or PCL deficiency or complex ligamentous instability of the study knee according to IKDC Grade C (abnormal) or D (severely abnormal).
Previous Surgery and Intervention Exclusions:
-
Previous surgery in the past 6 months on the index knee except for:
- Diagnostic knee arthroscopy and/or debridement / chondroplasty, and
- Meniscectomy
-
Previous intra-articular injections, including HA and steroids, within the last 3 months prior to the date of surgery.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Hyalex Cartilage System
Implantation of Hyalex Cartilage Knee Implant |
Implantation of Hyalex Cartilage Knee Implant. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Freedom from implant rejection and infection.
時間枠:Through 24 months.
|
Assess the safety (implant rejection, infection) and tolerability of the Hyalex Cartilage Implant. |
Through 24 months.
|
|
Change in the Knee Injury & Osteoarthritis Outcome Score (KOOS) from baseline at 12 months.
時間枠:Through 12 months.
|
The KOOS assesses patient pain, other symptoms, function in daily living, function in sport and recreation, and knee related quality of life. Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. |
Through 12 months.
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Marcin Domzalski, MD、SPORTO, Łódź, Poland
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。